SMMT Trading Analysis - 11/20/2026 10:28 AM โ€” TRU-SENTIMENT

SMMT (Summit Therapeutics Inc. Common Stock) at $10.56. True Sentiment Bullish, delta 40-60 call 85% / put 15%, call $7,570 vs put $1,330. RSI 31.7.

TRU-SENTIMENT ยท DeltaNeutral

SMMT Trading Analysis - 11/20/2026 10:28 AM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

SMMT (Summit Therapeutics Inc. Common Stock) at $10.56. True Sentiment Bullish, delta 40-60 call 85% / put 15%, call $7,570 vs put $1,330. RSI 31.7.

Symbol
SMMT
Price
$10.56
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-11-20 10:28:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment is Bullish. Call dollar volume $7,570.00 vs put $1,330.00; call pct 85.10%, put pct 14.90%. Call contracts 41, put 5. Pure directional positioning suggests near-term bullish conviction despite technical weakness. Divergence: option_spreads note "Options sentiment is Bullish but technicals are Bearish" with advice to wait for alignment. Sentiment source: tru-sentiment.com/quote/SMMT/options.

Call Volume: $7,570.00 (85.10%) Put Volume: $1,330.00 (14.90%) Total: $8,900.00

Key Statistics: SMMT

$10.56 +0.26%
52-Week Range
$10.14 - $29.23
Market Cap
$8.45B
P/E (TTM)
25.10
PEG Ratio
N/A
Beta
1.08
Next Earnings
N/A
Avg Volume
$5.24M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)25.10
EPS (trailing 12 mo)$-1.07
Market cap$8.45B
Shares outstanding799.8M

Dividend

Dividend yield0.00%

Risk & range

Beta1.08
52-week low$10.14
52-week high$29.23
Historical volatility109.7%

Ownership & trading

Institutional ownership7.3%
Average daily volume6.7M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below.

  • Summit Therapeutics (SMMT) reported earlier in 2026 a clinical update on its lead antibiotic program, with mixed efficacy readouts prompting analyst caution.
  • Biotech sector rotation intensified in November 2026 as investors favored profitable large-caps, pressuring small/mid-cap names like SMMT.
  • SMMT experienced a sharp volume spike on 2026-11-16 coinciding with a broad sector selloff and a disclosed secondary offering rumor.
  • No confirmed near-term earnings catalyst; next fiscal year end per fundamentals is 2025-12-01, with no current guidance refresh.
  • Headlines of weakening retail participation contrast with the embedded options data showing bullish delta-40-60 call conviction.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data: trailing P/E is 25.10, trailing EPS is -1.07 (negative profitability). Market cap is $8,447,507,250.00 with shares outstanding of 799,764,000.00. Dividend yield is 0.00% with no dividend rate. Beta is 1.08. 52-week high is $29.23 and 52-week low is $10.14. Institutional ownership is only 7.31%. Average volume is 6,685,000.00 and historical volatility is 109.70%.

Revenue growth, gross/operating/net margins, PEG ratio, price-to-book, ROE, debt-to-equity, and free cash flow are all null/unavailable in the data. Forward P/E and forward EPS are null. Analyst consensus, target mean price, and number of analyst opinions are null. The negative EPS with a positive trailing P/E of 25.10 indicates the ratio is not meaningful for profitability assessment. Low institutional percent (7.31%) and high historical volatility (109.70%) highlight speculative ownership. Fundamentals show no confirmed strength beyond scale (market cap ~$8.45B) and diverge from the bullish options sentiment since price is near 52-week low and earnings are negative.

Current Market Position

Current price per indicators is $10.54 (2026-11-19 close $10.54). Recent daily history shows a decline from $17.54 on 2026-10-09 to $10.54 on 2026-11-19, with a volume spike to 20,793,017 on 2026-11-16. Minute bars for 2026-11-19 to 2026-11-20 show open $10.34, high $10.94, low $10.30, close $10.54 on 2026-11-19; last bar 2026-11-20 10:00 has open $10.47, high $10.61, low $10.47, close $10.56, volume 121,724. Intraday momentum is mildly recovering from $10.26 at 09:45 to $10.56 at 10:00 on 2026-11-20.

Support
$10.14
Resistance
$11.65
Bollinger Lower
$10.39
SMA 5
$11.50

Technical Analysis

Technical Indicators

RSI (14)
31.74
MACD
-1.18
MACD Signal
-0.95
MACD Hist
-0.24
SMA 5
$11.50
SMA 20
$14.78
SMA 50
$15.90
BB Lower
$10.39
BB Middle
$14.78
BB Upper
$19.17
ATR 14
1.50

SMA alignment is bearish: price $10.54 below SMA 5 $11.50, SMA 20 $14.78, SMA 50 $15.90 (full bearish stack). RSI 31.74 shows oversold-leaning momentum but not extreme. MACD -1.18 below signal -0.95 with hist -0.24 confirms bearish momentum. Bollinger lower at $10.39 with price at $10.54 indicates price riding lower band (expansion). 30-day range high $18.15, low $10.14; price is at 1.9% above 30-day low, near bottom of range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment is Bullish. Call dollar volume $7,570.00 vs put $1,330.00; call pct 85.10%, put pct 14.90%. Call contracts 41, put 5. Pure directional positioning suggests near-term bullish conviction despite technical weakness. Divergence: option_spreads note "Options sentiment is Bullish but technicals are Bearish" with advice to wait for alignment. Sentiment source: tru-sentiment.com/quote/SMMT/options.

Call Volume: $7,570.00 (85.10%) Put Volume: $1,330.00 (14.90%) Total: $8,900.00

Key Price Levels (Observational Only)

52W Low / 30D Low
$10.14
Bollinger Lower
$10.39
Prior Close High 11-16
$11.65
SMA 5
$11.50
SMA 20 / BB Mid
$14.78

Interactive charts load with JavaScript. This text is the crawlable summary.